German Trade Distributors Stock News

XTRA:STM
XTRA:STMMachinery

Stabilus (XTRA:STM) Stock Looks Cheap As Automation Gains Gather Pace

Stabilus went into this earnings print looking bruised, with the stock at €15 and trailing 90‑day returns in decline. Yet Q3 landed with a very different story. The company produced about €299.5m of revenue and €2.07 basic earnings per share, and management kept full year guidance for around €1.15b of revenue and a roughly 10% adjusted earnings before interest and tax margin. The market is still pricing Stabilus on a modest 6.5x P/E despite a reported 9.3% earnings lift over the past year...
XTRA:P911
XTRA:P911Auto

Dr. Ing. h.c. F. Porsche (XTRA:P911) Reaffirms Outlook As Profit Improves And Value Stays In Focus

Dr. Ing. h.c. F. Porsche (XTRA:P911) shares reacted to fresh guidance and earnings news after the company reaffirmed its 2026 sales outlook while reporting higher half year net income on slightly lower sales. See our latest analysis for Dr. Ing. h.c. F. Porsche. The reaffirmed 2026 sales outlook and stronger half year profitability have come after a mixed run for Dr. Ing. h.c. F. Porsche, with the share price up 1.5% over 90 days but down 9.1% year to date, while the 1 year total shareholder...
XTRA:JUN3
XTRA:JUN3Machinery

Jungheinrich (XTRA:JUN3) Could Be 46% Undervalued As Lower Guidance Clouds Profit Outlook

Jungheinrich (XTRA:JUN3) lowered its full year 2026 earnings guidance after ongoing effects from a strike at its Lüneburg plant, higher material costs and continued competitive pressure weighed on expected profitability. See our latest analysis for Jungheinrich. At a share price of €25.04, Jungheinrich has seen only a small 1-day share price return of 2.88% and a modest 30-day share price return of 1.46%. The year-to-date share price return is down 30.56% and the 1-year total shareholder...
XTRA:BDT
XTRA:BDTProfessional Services

Bertrandt (XTRA:BDT) Stock Faces Revenue Slippage Despite Narrower Losses

Bertrandt stock came into this earnings print already bruised, with the share price down about 15% over the past three months and only flat over the past week. The headline from the release is simple and uncomfortable. Revenue in Q3 2026 sat at €217.3m while the company booked another net loss of €19.1m, leaving the trailing twelve month loss at €48.3m. The market is now being asked to decide whether this latest profit squeeze justifies the prior selloff or whether sentiment has swung too far...
XTRA:CHG
XTRA:CHGDiversified Financial

CHAPTERS Group (XTRA:CHG) Following Its Private Placement, Does The Valuation Still Look Pricey

Why CHAPTERS Group’s New Private Placement Matters For Investors CHAPTERS Group (XTRA:CHG) drew fresh attention on 22 July 2026 after announcing a private placement of 1,521,938 new shares at €42, raising €63,921,396 in gross proceeds. Subject to registration, the company’s share capital is set to move from €23,842,152.00 to €25,364,090.00, with four long term core shareholders and one additional institutional investor taking part in the deal. See our latest analysis for CHAPTERS...
XTRA:AG1
XTRA:AG1Specialty Retail

Is AUTO1 Group (XTRA:AG1) Fully Valued Following Its 2026 Guidance Confirmation?

AUTO1 Group (XTRA:AG1) confirmed its 2026 production guidance on 29 July 2026, giving investors a clearer view of expected unit volumes and segment mix across its digital used car platform in Europe. See our latest analysis for AUTO1 Group. Over the past year AUTO1 Group’s share price has been volatile, with a 90 day share price return of 24.55% but a year to date share price return that is down 19.64%. The 3 year total shareholder return of 152.46% contrasts with a 1 year total shareholder...
XTRA:FYB
XTRA:FYBBiotechs

European Growth Companies With Strong Insider Ownership August 2026

As European markets experience a positive shift, driven by better-than-expected corporate earnings and renewed interest in AI-related stocks, investors are increasingly focusing on companies with strong insider ownership as a potential indicator of confidence and alignment with shareholder interests. In this context, growth companies that demonstrate robust insider ownership can offer valuable insights into their long-term prospects amidst the current economic climate.
XTRA:HAG
XTRA:HAGAerospace & Defense

European Defense Stocks For Investors Watching Energy Infrastructure Risk

Geopolitical risk around Ukraine is again front and center, with renewed strikes on cities and energy assets, questions over missile defence support, and fresh EU aid discussions all feeding into European energy markets. For investors, this mix of conflict, infrastructure strain, and emergency public spending could reshape how certain stocks trade, especially those linked to energy systems and critical assets. This article looks at three European Energy Infrastructure screener stocks that...
XTRA:WAF
XTRA:WAFSemiconductor

Siltronic (XTRA:WAF) Cuts 2026 Sales View As Weaker Results Put Valuation In Focus

Siltronic (XTRA:WAF) came into focus after revising its 2026 guidance and releasing Q2 results that showed lower sales and a move from profit to loss. This highlighted tougher conditions for the wafer producer. See our latest analysis for Siltronic. The latest guidance cut and Q2 loss have come alongside a 7 day share price return of down 8.26% and a 30 day share price return of down 12.98%. However, Siltronic’s year to date share price return of 49.22% and 1 year total shareholder return of...
XTRA:DRW3
XTRA:DRW3Medical Equipment

Is Drägerwerk KGaA (XTRA:DRW3) Undervalued Following Strong Q2 2026 Earnings?

Drägerwerk KGaA (XTRA:DRW3) drew fresh attention after reporting second quarter 2026 earnings, with sales of €847.31 million and net income of €29.52 million compared with the prior year’s figures. See our latest analysis for Drägerwerk KGaA. The strong second quarter numbers arrived after a period of sharp share price gains for Drägerwerk KGaA, with the stock closing at €109.4 and showing a 30.55% 1 month share price return and 59.94% year to date share price return, alongside a 165.19% 3...
XTRA:MXHN
XTRA:MXHNMachinery

MAX Automation (XTRA:MXHN) Stock Struggles As Margin Squeeze Pushes Core Business Into Loss

MAX Automation stock closed at €3.71 on 31 July, roughly flat over the past week but slightly weaker over one and three months. The market seems hesitant rather than shocked. The headline in these full year numbers is the profit squeeze. The group generated €336.364m in trailing twelve month revenue yet still reported a loss from continuing operations of €4.404m and a negative Basic EPS of €0.106781. Short term traders see an unprofitable industrial group. Longer term investors will focus on...
XTRA:SMHN
XTRA:SMHNSemiconductor

SUSS MicroTec (XTRA:SMHN) Could Be 28% Undervalued On €45 Million Karlsruhe Expansion

SUSS MicroTec (XTRA:SMHN) has drawn fresh attention after announcing plans to invest about €45 million in a new application and development center in Karlsruhe, focused on Advanced Packaging for complex semiconductor systems. See our latest analysis for SUSS MicroTec. The Karlsruhe investment comes after a powerful share price run, with SUSS MicroTec posting an 82.17% year to date share price return and a 130.43% total shareholder return over the past year. This comes even as the 30 day share...
XTRA:FPE3
XTRA:FPE3Chemicals

Fuchs (XTRA:FPE3) Stock Margin Strength Meets Cash Flow Pressure

Fuchs shareholders watched a flat three month stretch turn into a modest pullback in the last week, even as the latest quarter put profit quality firmly in focus. The stock closed at €40.16, with the 7 day return slightly down and the 90 day line roughly unchanged. The headline from this earnings set is margin power. Q1 2026 net income reached €89m on €934m of revenue, and over the last 12 months earnings climbed to €318m with an 8.9% net margin. That is where sentiment and fundamentals now...
XTRA:SHL
XTRA:SHLMedical Equipment

Siemens Healthineers (XTRA:SHL) Tariff Refunds Cloud Underlying Earnings Strength

The market has treated Siemens Healthineers like a slow burner on a discount tag, with the stock at €36.86 and trading on a P/E below many medical equipment peers. Q3 results just reminded investors why the story is still complicated. The headline was not the revenue line; it was profit quality. Earnings received a sharp one off lift from tariff refunds that added about €0.15 to earnings per share and flattered margins. For you as a shareholder, the key question now is how much of this...
DB:1COV
DB:1COVChemicals

Covestro (DB:1COV) Stock Can Revenue Hold Up As Losses Deepen?

The market has spent the past few months treating Covestro as a recovery story, with the stock edging higher into the latest numbers. The earnings release instead lays bare a company still wrestling with heavy losses. Full year 2025 brought a reported loss of €644m on a trailing basis and a deeply negative basic earnings per share line, even as revenue sat above €12b. For a chemicals producer that lives and dies on throughput and margins, the headline is simple: sales are ticking along while...
XTRA:DWS
XTRA:DWSCapital Markets

The Bull Case For DWS Group GmbH KGaA (XTRA:DWS) Could Change Following Stronger Half-Year 2026 Earnings

DWS Group GmbH & Co. KGaA recently reported half-year 2026 results, with net income rising to €501 million from €413 million and basic and diluted EPS from continuing operations increasing to €2.51 from €2.06 a year earlier, highlighting stronger profitability over the period. The simultaneous increase in net income and per-share earnings suggests that improved profitability was not solely driven by balance sheet or share count changes, but by underlying business performance. Against this...
XTRA:BAS
XTRA:BASChemicals

BASF (XTRA:BAS) On Strong Q2 Earnings And Portfolio Shift Looks Modestly Undervalued

BASF (XTRA:BAS) is back on watch after its second quarter 2026 earnings, which showed sharply higher sales and net income, alongside fresh progress on product approvals and portfolio reshaping across key business segments. See our latest analysis for BASF. The BASF share price has risen 12.55% year to date and the 1 year total shareholder return of 25.83% suggests momentum has been positive overall, even though the 90 day share price return is down 7.93% following recent earnings and deal...